The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

CEL-SCI Corporation - Research and Development of Immunotherapy Products for Treatment of Cancer and Infectious Diseases

SNNLive spoke with Geert Kersten, CEO of CEL-SCI Corporation (NYSE MKT: CVM) at the Dawson James Small Cap Growth Conference 2015 in Jupiter, FL.

Share With

Tuesday, October 27, 2015

   

© 2017 Stock News Now